Accessibility Menu
 
Evotec Se logo

Evotec Se

(ETR) EVT

Current Price$5.14
Market Cap$942.10M
Since IPO (1999)-66%
5 Year-85%
1 Year-31%
1 Month+19%

Evotec Se Financials at a Glance

Market Cap

$942.10M

Revenue (TTM)

$788.37M

Net Income (TTM)

$103.52M

EPS (TTM)

$-0.58

P/E Ratio

-9.10

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$5.14

Volume

614,895

Open

$5.33

Previous Close

$5.14

Daily Range

$5.11 - $5.33

52-Week Range

$4.00 - $8.57

EVT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evotec Se

Industry

Life Sciences Tools and Services

Employees

4,553

CEO

Christian Wojczewski, PhD

Headquarters

Hamburg, 22419, DE

EVT Financials

Key Financial Metrics (TTM)

Gross Margin

14%

Operating Margin

-9%

Net Income Margin

-13%

Return on Equity

-12%

Return on Capital

-5%

Return on Assets

-6%

Earnings Yield

-10.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$942.10M

Shares Outstanding

177.59M

Volume

614.89K

Avg. Volume

878.02K

Financials (TTM)

Gross Profit

$65.24M

Operating Income

$140.87M

EBITDA

$41.40M

Operating Cash Flow

$9.44M

Capital Expenditure

$72.54M

Free Cash Flow

$81.98M

Cash & ST Invst.

$476.39M

Total Debt

$447.69M

Evotec Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$253.27M

+14.5%

Gross Profit

$78.46M

+70.2%

Gross Margin

30.98%

N/A

Market Cap

$942.10M

N/A

Market Cap/Employee

$197.67K

N/A

Employees

4,766

N/A

Net Income

$14.62M

+135.8%

EBITDA

$48.09M

+520.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$28.70M

+161.4%

Accounts Receivable

$213.51M

-2.2%

Inventory

$29.32M

-5.8%

Long Term Debt

$344.01M

-12.4%

Short Term Debt

$103.68M

+104.1%

Return on Assets

-5.82%

N/A

Return on Invested Capital

-4.82%

N/A

Free Cash Flow

$48.99M

-0.3%

Operating Cash Flow

$63.69M

-14.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EUZ.DEEckert & Ziegler Strahlen- und Medizintechnik AG
$15.10+0.27%
4LL.FTeladoc Health, Inc.
$5.15+2.41%
5CV.FCureVac N.V.
$3.91+0.00%
5CV.DECureVac N.V.
$3.91+0.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$84.52-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.74-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.14-0.01%
SOFISoFi Technologies
$18.36-0.02%

Questions About EVT

What is the current price of Evotec Se?

Evotec Se is trading at €5.14 per share.

What is the 52-week range for Evotec Se?

Over the past 52 weeks, Evotec Se has traded between €4.00 and €8.57.

How much debt does Evotec Se have?

As of the most recent reporting period, Evotec Se reported total debt of $447.69M.

How much cash does Evotec Se have on hand?

Evotec Se reported $418.52M in cash and cash equivalents in its most recent financial results.

What is Evotec Se’s dividend yield?

Evotec Se does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.